Reassessing use of statins for primary prevention in older adults
KEY POINT
In people older than age 74 years without diabetes, statin use for primary prevention was not associated with a reduction in the risk of atherosclerotic cardiovascular (CV) disease or all-cause mortality, with benefits seen only in those with diabetes who were between 75 and 84 years old, according to results of an observational study published in BMJ.
SOURCES
Ramos R, et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ. 2018;[Epub ahead of print].
Mortensen MB, et al. Primary prevention with statins in the elderly. J Am Coll Cardiol. 2017;71:85–94.
